SCHEMBL9872435

SCHEMBL9872435

OC/C=C/c1cccc(Cl)n1

nearest known ligand 0.45

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ NFE2L2 Q16236 8/20 0.45
▸ ALDH1A1 P00352 3/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ RECQL P46063 1/20 0.36
▸ TSHR P16473 1/20 0.35
▸ RHOA P61586 1/20 0.35
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ AGTR1 P30556 1/20 0.33
▸ APP P05067 5/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7311173 1.00 NFE2L2 (0.45) NFE2L2ALDH1A1CYP3A4RECQLTSHR
SCHEMBL10396763 0.82 NFE2L2 (0.46) NFE2L2ALDH1A1CYP3A4TSHRGAA
Hydrochloric Acid SCHEMBL7285456 0.81 NFE2L2 (0.45) NFE2L2ALDH1A1CYP3A4TSHRGAA
Hydrochloric Acid SCHEMBL9870847 0.81 NFE2L2 (0.45) NFE2L2ALDH1A1CYP3A4TSHRGAA
SCHEMBL10395615 0.81 NFE2L2 (0.45) NFE2L2ALDH1A1CYP3A4TSHRGAA
SCHEMBL12747839 0.77 CTH (0.39) ALDH1A1CYP3A4RECQLRHOAHPGD
SCHEMBL9000527 0.74 NFE2L2 (0.49) NFE2L2ALDH1A1CYP3A4TSHRMAPT
SCHEMBL9757025 0.72 KDM4E (0.53) NFE2L2CYP3A4TSHRGAA
SCHEMBL9756857 0.72 KDM4E (0.53) NFE2L2CYP3A4TSHRGAA
SCHEMBL31638135 0.71 NFE2L2 (0.50) NFE2L2ALDH1A1CYP3A4TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137541-A1 KINASE MODULATORS AND METHODS OF USE THEREOF NEURON23, INC. (US) 2025-06-26 — — WO disclosed
US-5068325-A Dopaminergic systems as hypotensives, sedatives, antitussives and/or antiphlogistics KARL THOMAE GMBH (DE) 1991-11-26 — — US disclosed
Send feedback